The Chronic Obstructive Pulmonary Disease (COPD) devices market is expected to see a steady increase in revenue from USD 8.3 billion in 2022 to USD 14.02 billion in 2032, with a Compound Annual Growth Rate (CAGR) of 6%. This growth is driven by several factors, including the increasing prevalence of COPD globally, a growing number of elderly people, and a rising demand for non-invasive devices. COPD is a chronic respiratory disease caused by long-term exposure to air pollutants such as smoking, dust, and other irritants. It is characterized by symptoms like emphysema, chronic bronchitis, and other respiratory conditions.
Get a free sample PDF of the report, visit @ https://www.reportsanddata.com/download-free-sample/5007
The increasing prevalence of COPD across the globe is expected to drive revenue growth of the market for COPD equipment, including inhalers, nebulizers, oxygen concentrators, and others. According to the World Health Organization (WHO), COPD is currently the third leading cause of death worldwide, and by 2030, it is projected to become the fifth most common cause of death. Moreover, the elderly population is estimated to reach 1.5 billion by 2050, which is expected to boost the market revenue. Furthermore, non-invasive and portable COPD devices are in high demand, particularly in home care settings, as they are easy to use and provide reliable results.
To know more about the latest insights of the report, visit @ https://www.reportsanddata.com/report-detail/chronic-obstructive-pulmonary-disease-devices-market
Governments across the world are taking action to raise awareness of COPD and to assist early detection and effective treatment of the condition, which is boosting market revenue. However, the high cost of COPD devices, absence of reimbursement regulations, and availability of alternative treatment alternatives are major factors that could restrain market revenue growth. Additionally, the effectiveness of surgical treatments for COPD, such as bullectomy and Lung Volume Reduction Surgery (LVRS), may lower the need for COPD devices.
Request a customized copy of the report @ https://www.reportsanddata.com/request-customization-form/5007
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact:
John W, Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]
LinkedIn | Twitter | Blogs
Browse for more reports…
https://www.reportsanddata.com/report-detail/fertility-enhancing-treatment-market
https://www.reportsanddata.com/report-detail/embolization-particles-market
https://www.reportsanddata.com/report-detail/hypnotics-and-sedatives-market
https://www.reportsanddata.com/report-detail/urinary-stone-treatment-devices-market
